A Phase 1 Placebo-Controlled Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Ascending Oral Doses Of PF-05175157 In Healthy Volunteers And In Patients With Type 2 Diabetes Mellitus (T2DM).
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2016
At a glance
- Drugs PF 5175157 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 21 Feb 2012 Actual patient number added 64 according to ClinicalTrials.gov.
- 21 Feb 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 21 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.